Inflammation Markers in Hyperemesis Gravidarum
NCT06245811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 215
Last updated 2024-02-07
Summary
In this study, the relationship between the severity of hyperemesis gravidarum (HEG) disease and subclinical inflammatory factors such as Platelet Crit (PCT), Hemoglobin/red cell distribution width ratio (HRR), Neutrophil/lymphocyte ratio (NLR), was investigated.
Conditions
- Hyperemesis Gravidarum
Sponsors & Collaborators
-
Izzet Celegen
lead OTHER
Principal Investigators
-
Kazım Uçkan · Yuzuncu Yıl University
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-20
- Primary Completion
- 2022-03-20
- Completion
- 2022-06-20
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
NCT03630276 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Anemia in Adolescent and Advanced Age Pregnancies
NCT05644964 ·Status: COMPLETED
-
Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker
NCT06873737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Docosahexaenoic Acid Serum Levels in Patients With Preeclampsia
NCT05591638 ·Status: UNKNOWN
-
Investigation of the Serum Mucoprotein 3 (MUC3) Protein Levels in Gestational Hypertensive Disease
NCT04421183 ·Status: COMPLETED
-
Nutritional Markers in Normal and Hyperemesis Pregnancies
NCT02619188 ·Status: UNKNOWN
-
Gallbladder Functions & Serum Cholecystokinin Levels in Women Diagnosed With Hyperemesis Gravidarum
NCT03950167 ·Status: COMPLETED
-
Promising Bimarker Prediction of Outcome of HELLP Syndrome.
NCT03246542 ·Status: COMPLETED
-
Effect of Different Maternal Hemoglobin and Hematocrit Values on Perinatal Outcome
NCT06726915 ·Status: NOT_YET_RECRUITING
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Hyperemesis Gravidarum and 75 Gram Oral Glucose Tolerance Test
NCT02963753 ·Status: COMPLETED
-
Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia
NCT01388283 ·Status: COMPLETED
-
Kidney Injury Biomarkers in Preeclampsia
NCT03217916 ·Status: UNKNOWN
-
Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach
NCT06372938 ·Status: ACTIVE_NOT_RECRUITING
-
İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels?
NCT01906567 ·Status: UNKNOWN
-
Study of Biological Determinants of Bleeding Postpartum
NCT02884804 ·Status: COMPLETED
-
Proteomics/Modifier Based on Mass Spectrometry Reveals the Pathogenesis of Eclampsia During Pregnancy and the Screening of Disease Markers
NCT04833881 ·Status: UNKNOWN
-
Are Uterine Natural Killer Cells Involved in the Initiation of Preterm Labor ?
NCT02284867 ·Status: COMPLETED
-
Prognosis in Pregnant With COVID-19
NCT04409249 ·Status: COMPLETED
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
Investigating CD 71 in Preeclamptic Pregnancies
NCT06668545 ·Status: COMPLETED
-
Prostasin Levels in Preeclamptic Women
NCT06623942 ·Status: COMPLETED
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women
NCT05622838 ·Status: UNKNOWN
-
Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome
NCT03232359 ·Status: COMPLETED